During the past decade, Allmedica Badania Kliniczne Sp z o.o. Sp K. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allmedica Badania Kliniczne Sp z o.o. Sp K." #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Allmedica Badania Kliniczne Sp z o.o. Sp K." are "Ulcerative Colitis" (5 trials), "Crohn Disease" (2 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Allmedica Badania Kliniczne Sp z o.o. Sp K." in a lesser frequency.

Most popular intervention types in "Allmedica Badania Kliniczne Sp z o.o. Sp K." are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrasimod" (4 trials), "Etrolizumab" (4 trials), "Placebo" (4 trials), "Adalimumab" (1 trials) and "Adalimumab Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allmedica Badania Kliniczne Sp z o.o. Sp K." are 8 trials for "All" genders.

Currently, there are NaN active trials in "Allmedica Badania Kliniczne Sp z o.o. Sp K.". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Allmedica Badania Kliniczne Sp z o.o. Sp K., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allmedica Badania Kliniczne Sp z o.o. Sp K., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".